Biotechnologies Assets SA (BST.MC)

EUR 0.29

(-5.84%)

Inventory Summary of Biotechnologies Assets SA

  • Biotechnologies Assets SA's latest annual inventory in 2023 was -3.15 Million EUR , down 0.0% from previous year.
  • Biotechnologies Assets SA's latest quarterly inventory in 2023 FY was - EUR , down 0.0% from previous quarter.
  • Biotechnologies Assets SA reported annual inventory of - EUR in 2022, down 0.0% from previous year.
  • Biotechnologies Assets SA reported annual inventory of - EUR in 2021, down -100.0% from previous year.
  • Biotechnologies Assets SA reported quarterly inventory of -3.15 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Biotechnologies Assets SA reported quarterly inventory of - EUR for 2023 Q1, down 0.0% from previous quarter.

Annual Inventory Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Inventory of Biotechnologies Assets SA (2023 - 2010)

Year Inventory Inventory Growth
2023 -3.15 Million EUR 0.0%
2022 - EUR 0.0%
2021 - EUR -100.0%
2020 18.13 Thousand EUR -99.74%
2019 7.04 Million EUR 7.38%
2018 6.55 Million EUR 14637.41%
2017 44.49 Thousand EUR -32.4%
2016 65.82 Thousand EUR 18.37%
2015 55.6 Thousand EUR 97.14%
2014 28.2 Thousand EUR -32.48%
2013 41.77 Thousand EUR -54.98%
2012 92.78 Thousand EUR 0.0%
2011 - EUR 0.0%
2010 - EUR 0.0%

Peer Inventory Comparison of Biotechnologies Assets SA

Name Inventory Inventory Difference
Atrys Health, S.A. 1.67 Million EUR 288.161%
Oryzon Genomics S.A. 6029.00 EUR 52438.132%
Pharma Mar, S.A. 39.28 Million EUR 108.031%
Laboratorios Farmaceuticos Rovi, S.A. 337.96 Million EUR 100.934%